MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

A-674563

CAS No. : 552325-73-2

MCE 站：A-674563

产品活性：A-674563 是口服有效，选择性的 Akt1 抑制剂，K_i 为 11 nM。

研究领域：PI3K/Akt/mTOR

作用靶点：Akt

In Vitro: A-674563 slows proliferation of tumor cells with an EC₅₀ of 0.4 μM.
A563 (0-10 µM) significantly decreases GSK3 ａnd MDM2 phosphorylation in STS cells. A563 shows inhibitory effect on all STS cell lines, with IC₅₀ values at 48 hours ranging from 0.22 µM (SW684) to 0.35 µM (SKLMS1). A563 induces G2 cell cycle arrest ａnd apoptosis in STS cells. A563 (1 µM/12 hr) upregulates the expression of GADD45A independent of p53.
A-674563 (10-1000 nM) is anti-proliferative ａnd cytotoxic in cultured human melanoma cells, induces melanoma cell apoptotic death, inhibited by caspase inhibitors, ａnd inhibits melanoma cells via Akt-dependent ａnd -independent mechanisms.
A-674563 is cytotoxic ａnd anti-proliferative when added to U937 ａnd AmL progenitor cells, activates caspase-3/9 ａnd apoptosis in U937 ａnd AmL progenitor cells, ａnd manipulates other signalings in AmL cells whiling blocking Akt.

In Vivo: A-674563 (40 mg/kg/d, p.o.) shows no significant monotherapy activity, but the efficacy of the combination therapy (A-674563+paclitaxel) is significantly improved in the PC-3 prostate cancer xenograft model. A-674563 (20, 100 mg/kg) increases plasma insulin in an oral glucose tolerance test.
A563 (20 mg/kg/bid; p.o.) exhibits slow tumor growth ａnd a significant difference in tumor volume without significant weight loss of mice. A563-treated tumors express increased levels of GADD45α ａnd decreased levels of PCNA (a nuclear marker for proliferation). Additionally, TUNEL assay staining levels (marker for apoptosis) increase in the A563-treated specimens.
A-674563 (25, 100 mg/kg, lavage daily) potently inhibits A375 xenograft growth in mice.
A-674563 (15, 40 mg/kg) injection inhibits U937 xenograft in vivo growth, ａnd improves mice survival.

相关产品：Bioactive Compound Library Plus  |  Kinase Inhibitor Library  |  PI3K/Akt/mTOR Compound Library  |  Stem Cell Signaling Compound Library  |  Anti-Cancer Compound Library  |  Autophagy Compound Library  |  Anti-Aging Compound Library  |  Differentiation Inducing Compound Library  |  Oxygen Sensing Compound Library  |  Glycolysis Compound Library  |  Cytoskeleton Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Breast Cancer Compound Library  |  Anti-Lung Cancer Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  Honokiol  |  GSK-690693  |  Artemisinin  |  Perifosine  |  Oridonin  |  Guggulsterone  |  Miransertib  |  SU6656  |  Triciribine  |  Scutellarin  |  Isobavachalcone  |  Recilisib  |  Deguelin  |  A-674563 hydrochloride  |  Miltefosine  |  YS-49  |  α-Linolenic acid  |  Urolithin B  |  Pachymic acid  |  3CAI  |  Polyphyllin I  |  1,3-Dicaffeoylquinic acid  |  Esculetin  |  Licochalcone E  |  Cyclovirobuxine D  |  GSK2110183 analog 1 hydrochloride  |  SC66  |  Akt1 ａnd Akt2-IN-1  |  Arnicolide D

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。